Abstract: Embodiments of this application provide a network slice adjustment method and apparatus, applied to the network slice field. The method may include: A slice configuration network element receives service experience information from a terminal device that not only includes identifier information of a base station and identifier information of a network slice corresponding to a service, but also include quality of service indicator information and/or service user experience information. Then, the slice configuration network element may determine, based on the service experience information, that the base station corresponding to an identifier of the base station cannot meet the service, and adjusta network slice supported by the base station. Further, in embodiments of this application, configuration of the network slice supported by the base station may be automatically optimized, so as to avoid a case in which the service of a user is adversely affected.

Abstract: The invention concerns a sonocatalyst which is suitable for promoting a chemical reaction initiated by ultrasound irradiation. The invention also relates to a method of catalysing a reaction by exposing the sonocatalyst to ultrasound. The invention also relates to the use of a sonocatalyst as described herein in a method as described herein.

Abstract: Abstract: The present invention provides a core-shell micro-particle comprising a biodegradable polymer with at least two or more surface cavities. The present invention also provides use of the core-shell micro-particle in drug delivery, contrast enhancement, subharmonic imaging enhancement, theranostics, and/or any combination of the aforementioned applications.

Abstract: The present invention provides a core-shell microparticle comprising a biodegradable polymer with at least two or more surface cavities for use in the treatment of vascular disease, wherein the shell further comprises one or more drugs. The present invention further provides a core-shell microparticle which can be used for such treatments, the microparticle comprising a biodegradable polymer with at least two or more surface cavities, wherein the shell further comprises one or more drugs, wherein the one or more drugs are selected from anti-inflammatory drugs, immunosuppressants, anti-proliferative drugs, anti-coagulants and combinations thereof.